With the release of the 2022 AHA/ACC Guidelines for the Management of Heart Failure, patients with HFpEF now have a wider range of treatment options.
Meghan Perry, PharmD candidate
Advertisement
Articles by Meghan Perry, PharmD candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Subcutaneous Isatuximab Could Compete With Daratumumab in Multiple Myeloma
2
FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening
3
Beyond Off-Label: How Auvelity's Approval Changes Agitation Management in Alzheimer Disease
4
Vaccine Guidance Is Rapidly Changing—Here's What You Need to Know
5